"O Centro de Investigação em Saúde de Manhiça (CISM) criado em 1996, é um centro de investigação consolidado, altamente especializado e com forte capacidade de investigação em doenças transmissíveis prevalentes em Moçambique, com particular enfoque às principais causas de morbi-mortalidade no país (malária, HIV/SIDA, tuberculose e doenças bacterianas). A actuação do CISM centra-se na pesquisa. Para tal, conta com plataformas de pesquisa (vigilância geográfica e demográfica e vigilância de morbilidade), serviços de apoio à pesquisa (laboratório, tecnologia de informação, gestão e análise de dados) e formação. O CISM é gerido pela Fundação Manhiça."

During the past decade, Centro de Investigaçao em Saude de Manhiça conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Investigaçao em Saude de Manhiça" #1 sponsor was "Barcelona Institute for Global Health" with 4 trials, followed by "Centro de Investigacao em Saude de Manhica" with 4 trials sponsored, "Hospital Clinic of Barcelona" with 3 trials sponsored, "Foundation for Innovative New Diagnostics, Switzerland" with 2 trials sponsored and "Save the Children" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Investigaçao em Saude de Manhiça" #1 collaborator was "Centro de Investigação em Saúde de Manhiça" with 6 trials as a collaborator, "Barcelona Institute for Global Health" with 3 trials as a collaborator, "Aga Khan University" with 2 trials as a collaborator, "Bernhard Nocht Institute for Tropical Medicine" with 2 trials as a collaborator and "Centre de Recherche Médicale de Lambaréné" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Investigaçao em Saude de Manhiça" are "Malaria" (9 trials), "Diagnoses Disease" (2 trials), "Pregnancy Related" (2 trials), "Tuberculosis" (2 trials) and "Acute Respiratory Infection" (1 trials). Many other conditions were trialed in "Centro de Investigaçao em Saude de Manhiça" in a lesser frequency.

Most popular intervention types in "Centro de Investigaçao em Saude de Manhiça" are "Drug" (9 trials), "Diagnostic Test" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Coartem™ (Artemether-lumefantrine combination)" (2 trials), "Placebo" (2 trials), "Sulfadoxine-Pyrimethamine (Fansidar)" (2 trials), "Chloroquine" (1 trials) and "Coarsucam™ (Amodiaquine-artesunate combination)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigaçao em Saude de Manhiça" are 10 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro de Investigaçao em Saude de Manhiça". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centro de Investigaçao em Saude de Manhiça, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigaçao em Saude de Manhiça, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".